Explore the potentialities of two novel EPS produced by two Leuconostoc mesenteroides strains in modulating the gut microbiota.
Exopolysaccharides (EPS) by lactic acid bacteria (LAB) can resist gastrointestinal digestion and be fermented by the human gut microbiota leading to positive effects on human health1. As the properties of EPS are strain – dependent, the research for novel EPS with exploitable health benefits is of interest.